6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
ID: 36C77026Q0061Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/eb23cebd6cbe44599d7f6f7df01651d1/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-1976
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77026Q0061_1.docx
    The Department of Veterans Affairs (VA) Consolidated Mail Outpatient Pharmacy (CMOP) has issued a Request for Information (RFI) to identify domestic small and large business pharmaceutical manufacturers. This RFI, designated 36C77026Q0061, is for market research and procurement planning purposes only and does not constitute a solicitation for a contract. The VA is seeking information on manufacturers of pharmaceuticals and ancillary items to support CMOP's Open Market (OM) purchases, which supplement their Prime Vendor contract. The scope includes items under NAICS codes 325412 (Pharmaceutical Preparation Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing). Interested manufacturers are requested to submit company, product, operational capability, and contracting information by March 15, 2026, at 4:30 PM CT, demonstrating compliance with federal, state, and local regulations and the capacity to support seven CMOP sites.
    P02_Sources Sought_Attch1_Manufacturer Inputs_Excel.xlsx
    The document outlines requirements for the acquisition planning of commercially available pharmaceutical items. It details specific information required for each pharmaceutical product, including active ingredients, generic name, manufacturer specifics (name, generic drug name), FDA Approved NDC(s) #, FDA Approval #, certification of regulatory compliance, physical address of manufacturing facility, manufacturing capacity, and treatment usage. The request emphasizes that only NDCs with FDA approval should be submitted and must be reflective of the manufacturer, not a repackager. Additional information sought includes existing agency-wide contracts, frequency of stockouts, SAM UEI #, commercial entities where products are sold, average commercial cost per pill, and authorized distributors with state licenses and socio-economic status. A comprehensive list of pharmaceutical products with their descriptions and treatment usages is also provided, ranging from various medications (e.g., ABALOPARATIDE, ACAMPROSATE CA, IBUPROFEN) to medical supplies (e.g., BREAST MILK STORAGE BAGS, CATH SETS). The document underscores the need for fair and reasonable pricing for these open market items.
    Lifecycle
    Title
    Type
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Currently viewing
    Sources Sought
    Similar Opportunities
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    DA01--Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a software solution aimed at reducing inappropriate polypharmacy among Veterans, as outlined in the presolicitation notice for Request for Information (RFI) number 36C10B25Q0550. The objective is to identify multi-drug interactions, optimize medication regimens, and support deprescribing through sophisticated, clinically-evidenced technology that adheres to VA's IT standards and ensures secure handling of patient data. This initiative is critical for improving medication management and clinical outcomes for Veterans, with a formal Request for Proposal (RFP) to be issued via Contracting Opportunities. Interested parties must ensure full registration in the System for Award Management (SAM.gov) and submit their responses by September 15, 2025, at 3 PM Eastern Time. For inquiries, contact Contract Specialist Elena Juliano at elena.juliano@va.gov or Contracting Officer John Vardouniotis at ioannis.vardouniotis@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Q517--FY26: VISN 8 Pharmacy Emergent First Fill Prescription Services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 8 (NCO 8), is seeking qualified contractors to provide Emergent First Fill Prescription Services for VA beneficiaries within VISN 8, which includes locations in Florida and Puerto Rico. The procurement involves a Firm Fixed Indefinite Delivery Indefinite Quantity contract, covering a base period plus four option years, to deliver 24/7 pharmaceutical benefits management services, including filling new prescriptions and adhering to a specific emergency medication formulary. This service is crucial for ensuring timely access to medications for veterans in emergency situations, with strict requirements for confidentiality and compliance. Quotes are due by December 30, 2025, at 10:00 AM EST, and interested parties should direct inquiries to Contracting Officer Colleen Houser at colleen.houser@va.gov or by phone at 727-201-6880.
    DA01--New Contract - Polypharmacy (VA-26-00018584)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a new contract titled "Reducing Inappropriate Polypharmacy" to address medication management issues within the VA healthcare system. The procurement aims to develop and implement software solutions that will enhance program management, pilot phases, and sustainment of services, with an estimated total award amount of $47 million over a base period of six months and four one-year option periods. This initiative is critical for improving patient care and reducing the risks associated with polypharmacy among veterans. Interested parties must respond to the solicitation by January 14, 2026, at 10 AM Eastern Time, and can contact Contract Specialist Elena Juliano at elena.juliano@va.gov or 848-377-5194 for further information.
    Tucson CMOP COAL TAR 2% SHAMPOO 240ML AND MOISTURIZING LOTION
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Coal Tar 2% Shampoo and Moisturizing Lotion under Solicitation Number 36C77026Q0057, with a focus on pharmaceutical preparation manufacturing. This procurement is a Total Small Business Set-Aside and includes specific requirements such as the submission of a signed SF1449, a completed pricing schedule, and compliance with the Buy American Act. The products are essential for the treatment of various dermatological conditions among veterans, and all items must have a minimum expiration date of one year from the delivery date. Interested vendors should submit their quotes via email to Sarah Fry at sarah.fry2@va.gov by the extended deadline of January 12, 2026, at 4:00 PM CST.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.